RXL:NYE-ProShares Ultra Health Care (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 45.62

Change

0.00 (0.00)%

Market Cap

N/A

Volume

1.30K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-18 )

ETFs Containing RXL

KGHG 4.13 % 0.00 %

N/A

N/A
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

N/A

USD 0.09B
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

N/A

USD 8.38B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

N/A

N/A
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 0.20B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.00 % 0.00 %

N/A

USD 0.17B
1388:TSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.71% 42% F 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.71% 42% F 75% C
Trailing 12 Months  
Capital Gain -4.26% 17% F 21% F
Dividend Return 1.62% 71% C- 26% F
Total Return -2.64% 17% F 19% F
Trailing 5 Years  
Capital Gain 36.54% 65% D 68% D+
Dividend Return 3.89% 69% C- 10% F
Total Return 40.43% 65% D 63% D
Average Annual (5 Year Horizon)  
Capital Gain 11.82% 30% F 68% D+
Dividend Return 12.12% 28% F 64% D
Total Return 0.30% 22% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 31.39% 97% N/A 34% F
Risk Adjusted Return 38.63% 66% D+ 53% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.